In bleomycin‐induced pulmonary hypertension, KP-13 was reported to reduce fibrosis by repressing tumor necrosis factor-α (Tnf), transforming growth factor-β (Tgfb), and collagen type Iα1 (Col1a1) [30]. This evidence concerns the gene TNF and pulmonary arterial hypertension.